SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
STOP-SHOCK
1 other identifier
observational
2,500
1 country
1
Brief Summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 14, 2017
CompletedFirst Posted
Study publicly available on registry
October 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2031
October 7, 2021
September 1, 2021
13.3 years
October 14, 2017
September 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
All-cause mortality
by registration office
Within 30 days after admission.
Secondary Outcomes (3)
Ischemic events, bleeding events, heart failure, sepsis, dialysis.
Within 30 days after admission.
All-cause mortality
Within 12 months after admission.
Ischemic events, bleeding events, heart failure, sepsis, dialysis.
Within 12 months after admission.
Eligibility Criteria
Patients admitted to a tertiary care hospital.
You may qualify if:
- Patients with cardiogenic shock treated at a tertiary care hospital.
You may not qualify if:
- Age ≤17 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Heart Center
Hamburg, Germany
Related Publications (1)
Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Moller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Mobius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schafer A, Westermann D. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 2019 Mar 5;139(10):1249-1258. doi: 10.1161/CIRCULATIONAHA.118.036614.
PMID: 30586755DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dirk Westermann, MD
UHZ
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 14, 2017
First Posted
October 18, 2017
Study Start
September 1, 2017
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2031
Last Updated
October 7, 2021
Record last verified: 2021-09